The Fairview Equity Partners Emerging Companies Fund

The Fairview Equity Partners Emerging Companies Fund has outperformed the benchmark S&P/ASX Small Ordinaries Accumulation Index by +7.09% p.a since inception (8 October 2008) for the period ending 31 October 2019.

When you invest in the Fund, you're not buying an index or a sector, you're harnessing Fairview's commitment to diligently researching and identifying mis-priced companies within the small caps sector.

Portfolio Managers Michael Glenane, Leo Barry, Tim Hall
Fund size (at 31 December 2018) $331 million
Inception date 8/10/2008
Benchmark S&P/ASX Small Ordinaries Accumulation Index
Management Fee 1.20% p.a of the Fund’s net asset value 
Performance Fee 20.5% of the Fund’s quarterly return (after deducting the Management fee) in excess of the Benchmark’s quarterly
return after recouping any prior periods’ underperformance in dollar terms multiplied by the Fund’s average net asset value over the quarter.
Typical number of stocks 50 - 65
Buy/Sell spread +0.30% on application and -0.30% on withdrawal
APIR code ANT0002AU
Distribution frequency Yearly, calculated as at 30 June. However, there may be periods in which no distributions are made or special distributions are paid.

Further information

Why Fairview?

• Returns – our core active investment approach and tight risk controls allow us to consistently deliver solid returns throughout the various stages of each investment cycle.

• Capacity – we have firm capacity constraints in place to ensure returns aren’t compromised due to excessive levels of funds under management.

• Experience – we have worked together for several years and collectively have in excess of 55 years of investment experience, specialising in funds management and investment research.

• Diversification – we comprehensively cover the small caps universe to build a diversified high quality portfolio of our most compelling investments opportunities.

• Alignment – we have invested a considerable portion of our own personal wealth into the Fund. To this end, we are totally aligned with investors in our efforts to maximize unitholder returns. 

Further information

Investment objective

The Fund aims to earn a return (after fees) which exceeds the Benchmark over rolling five-year periods.

Further information


Source Publication date Title


January 2018 Rated


February 2018 Rated
Morningstar September 2018 Rated


Ratings Disclaimer.

Further information